Skip to main content
In this edition, we bring you important updates on the rise of COVID-19 cases, the emergence of Alpha-gal Syndrome, and a new illicit drug causing concern in Delaware.

COVID Cases on the Rise: FLiRT to Blame

This summer, COVID-19 cases are increasing across the US, driven by summer travel and gatherings.  Delaware has experienced a modest rise, but nationwide, ER visits for COVID have surged by 115%. Learn more about how to stay safe in the full article here.

Alpha-gal Syndrome Now Reportable in Delaware

The Delaware Division of Public Health (DPH) has identified six cases of Alpha-gal Syndrome (AGS), making it a newly reportable condition in the state. AGS causes an allergy to mammalian meat due to lone star tick bites, presenting symptoms such as hives and gastrointestinal distress. For more details on AGS and preventive measures, read the full article here.

New Illicit Drug Hitting the Streets: Medetomidine

Delaware’s Opioid Response Team (ORT) has issued a warning about a new illicit drug, medetomidine, a potent veterinary tranquilizer more powerful than xylazine. Not approved for human use, medetomidine can cause significant sedation, low heart rate, and, in extreme cases, central nervous system depression and death. Providers are advised to start overdose treatment with Naloxone and monitor symptoms. For more information, read the full article here.